Since the outbreak of the coronavirus, up to now (data on February 26) the cumulative number of confirmed diagnoses nationwide has reached 77,788 in China, the cumulative death toll has reached 2,666, and the cumulative number of cured and discharged people is 27,718.
In response to the pandemic, Apex Biotech, a biotechnology company under the UPcare Group of Australia has successfully developed a spray product that has anti-respiratory infection and can improve immunity-UPplus KBD Spray, and has been approved by Australia authority as a broad-spectrum anti-respiratory tract infection spray. This product has been used by confirmed patients and many family members with suspected infections, and assisted treatment until recovery and discharge. The first batch of products have been donated to Wuhan, and further clinical tests are underway, hoping to play a positive role in the prevention and treatment of the virus.
It is understood that UPplus spray is a 100% pure natural extract, and strictly manufactured in Australia by GMP complied laboratories. The the product registration number is AUST L 329895 as listed on the ARTG.
Product principle: The product can significantly improve immunity, inhibit infections and reduce bacteria/viruses from entering the lungs from the respiratory tract.
Benefits:
✓ Reduce upper respiratory tract infection
✓ Improve immunity
✓ Relieve throat discomfort
The first batch of UPPlus medicines has been put into production, and medcines have been been donated to the Wuhan epidemic area in batches.
The first batch of UPPlus products arrived in Wuhan to support front-line medical staff to boost respiratory health and start further clinical testing.
It is reported that this spray of UPplus requires a certain difficult production process and needs to be delivered in batches. It is expected that it will not be available in Australia until early March at the earliest.
UPcare Group seeks further cooperation to fund raising of clinical trials, increase the scale of production, and give priority to delivery to the epidemic area.
Company Profile
UPCare Group Pty Ltd was founded in Melbourne, Australia by a group of leading scientists and researchers to address the growing concerns and proliferation of viruses and other transmitted illnesses contracted through the human respiratory functions.
Contact information
Email: enquiries@upcare.tech
Phone ☎️: 1300 468 686
Comments